EXEL:
Analysis & Opinions
-
January 18, 2013
Exelixis, Inc. (EXEL) recently announced that it has received a notice from its partner, Roche Holding (RHHBY), ...
-
October 23, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq has decreased 0.8%; the S&P 500 is down ...
-
November 03, 2011
Dendreon's Provenge continues to shape up as a major disappointment.
-
June 07, 2011
Investors shouldn't be spooked by the normal post-ASCO sell-off
-
July 06, 2010
The stock market may have had a terrible performance in June, but many stocks have defied the negative market trend.
-
May 13, 2010
Adaptive design is an idea whose time has come, and investors in biotechs and pharmaceuticals should stand to benefit.
-
November 18, 2009
Fourth healthcare stocks that have brushed aside any potential adversity that could arise from future legislation ...
